![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1175-9046
Source: Pharmaceutical Development and Regulation, Vol.1, Iss.3, 2003-01, pp. : 169-177
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacoeconomics in Healthcare Decision Making in China
By Li Hai-tao
Pharmaceutical Medicine, Vol. 23, Iss. 5-6, 2009-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Using pharmacoeconomics to justify use of higher-cost drugs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 390, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacoeconomics + efficacy required in HIV drug research
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 484, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacoeconomics of voriconazole
By Rubio-Terrés Carlos Grau Santiago
Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. :